Michael Wang, MD
Neurological Surgery · Miami, FLNPI 1053347906
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.5%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 31.4% of the total. Among neurological surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,142 payments — averaging $1924.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$690K
- Medical Device Business Services, Inc.$373K
- Medtronic$332K
- Stryker$261K
- Spineology Inc.$172K
- Globus Medical$128K
- plus $242K from 34 others
Across 27 payments — averaging $14,853 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Spineology Inc.$256K
- Pfizer$145K
- Medtronic$450
What the payments were for
- Royalty or licence$818,28337%
- Consulting fees$1,132,53752%
- Speaking & faculty fees$89,2384%
- Travel & lodging$104,9905%
- Food & beverage$42,0082%
- Education$100%
- Gifts$40%
- Entertainment$5990%
- Ownership interest$10,4000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPEDIUM$655,169
- VIPER$262,430
- EXPAREL$229,412
- STRATAFIX$135,705
- CONCORDE$132,569
- DERMABOND$126,160
- OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM$101,316
- SPOTLIGHT$98,151
- Oracle$98,151
- MONOCRYL$87,565
- PDS$87,565
- SURGIFLO Hemostatic Matrix$68,890
- RELINE$61,559
- Xvision$54,445
- EVEREST SPINAL SYSTEM$49,402
- SAHARA STABILIZATION SYSTEM$48,259
- MAKO$36,233
- Rampart Duo Interbody Fusion System$35,195
- AVIATOR$29,840
- SAHARA$29,521
How this compares
$2,198,069 in reported general payments places this provider in the 95th percentile of 556 neurological surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 474 | $6,014 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 155 | $4,853 |
| Naloxone Hcl | 47 | $2,802 |
| Tizanidine Hcl | 168 | $2,560 |
| Pregabalin | 107 | $2,296 |
| Celecoxib | 87 | $2,037 |
| Cyclobenzaprine Hcl | 137 | $1,746 |
| Methylprednisolone | 192 | $1,382 |
| Meloxicam | 448 | $1,223 |
| Diclofenac Sodium | 70 | $1,214 |
| Baclofen | 58 | $1,099 |
| Tramadol Hcl | 164 | $878 |
| Hydromorphone Hcl | 18 | $394 |
| Methocarbamol | 27 | $342 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $300 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Miami
- Eric PetersonMiami$10.1M
- Wilson AsforaMiami$1.3M
- Steven VanniMiami$1.1M
- Timur UrakovMiami$652K
- Samuel GoldsmitMiami$519K
- Robert StarkeMiami$302K
- Ian CoteMiami$231K
- Michael IvanMiami$225K
- James GuestMiami$155K
- Stephen ParkerJacksonville$18.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.